Production (Stage)
enGene Holdings Inc.
ENGN
$3.33
$0.082.46%
NASDAQ
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.16% | 7.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.92% | 52.47% | |||
| Operating Income | -1.92% | -52.47% | |||
| Income Before Tax | -3.97% | -60.98% | |||
| Income Tax Expenses | 1,233.33% | -5.26% | |||
| Earnings from Continuing Operations | -4.87% | -60.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.87% | -60.90% | |||
| EBIT | -1.92% | -52.47% | |||
| EBITDA | -1.91% | -52.08% | |||
| EPS Basic | -4.78% | -40.26% | |||
| Normalized Basic EPS | -3.88% | -40.34% | |||
| EPS Diluted | -4.78% | -40.26% | |||
| Normalized Diluted EPS | -3.88% | -40.34% | |||
| Average Basic Shares Outstanding | 0.08% | 14.72% | |||
| Average Diluted Shares Outstanding | 0.08% | 14.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||